Cours Acura Pharmaceuticals, Inc. OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2020 | 3,57 M 3,16 M | CA 2021 | 1,56 M 1,38 M | Capitalisation | 32,54 M 28,78 M |
---|---|---|---|---|---|
Résultat net 2020 | -1 M -884 k | Résultat net 2021 | - 0 | VE / CA 2020 | 2,91 x |
Dette nette 2020 | 5,86 M 5,18 M | Dette nette 2021 | 135 k 119 k | VE / CA 2021 | 20,9 x |
PER 2020 |
-5,25
x | PER 2021 |
-25
x | Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 15,72% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/03/98 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/03/98 |
William Skelly
BRD | Director/Board Member | 73 | 01/05/96 |
Varia. 1 janv. | Capi. | |
---|---|---|
+20,03% | 126 Md | |
+23,61% | 118 Md | |
+23,26% | 27,87 Md | |
-18,07% | 20,95 Md | |
-15,13% | 16,92 Md | |
-14,81% | 16,18 Md | |
+9,78% | 14,84 Md | |
-46,10% | 14,79 Md | |
+52,34% | 14,08 Md |
- Bourse
- Actions
- Action ACUR
- Action